Detalhe da pesquisa
1.
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans.
Cell
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38761800
2.
After the pandemic: perspectives on the future trajectory of COVID-19.
Nature
; 596(7873): 495-504, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34237771
3.
Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features.
Proc Natl Acad Sci U S A
; 121(4): e2308942121, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38241441
4.
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S.
N Engl J Med
; 386(9): 847-860, 2022 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139271
5.
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
N Engl J Med
; 386(6): 531-543, 2022 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34910859
6.
Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials.
PLoS Pathog
; 19(6): e1011469, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37384759
7.
COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials.
Clin Infect Dis
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38598658
8.
Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.
PLoS Med
; 21(3): e1004360, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38502656
9.
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
N Engl J Med
; 384(23): 2187-2201, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33882225
10.
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
N Engl J Med
; 385(19): 1774-1785, 2021 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34551225
11.
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.
N Engl J Med
; 384(11): 1003-1014, 2021 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33730454
12.
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.
N Engl J Med
; 385(25): 2348-2360, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34587382
13.
Chimeric TIM-4 receptor-modified T cells targeting phosphatidylserine mediates both cytotoxic anti-tumor responses and phagocytic uptake of tumor-associated antigen for T cell cross-presentation.
Mol Ther
; 31(7): 2132-2153, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37194236
14.
Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study.
J Infect Dis
; 227(8): 939-950, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36348617
15.
Protein dose-sparing effect of AS01B adjuvant in a randomized preventive HIV vaccine trial of ALVAC-HIV (vCP2438) and adjuvanted bivalent subtype C gp120.
J Infect Dis
; 2023 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37795976
16.
Impact of Point-of-Care Testing on the Management of Sexually Transmitted Infections in South Africa: Evidence from the HVTN702 Human Immunodeficiency Virus Vaccine Trial.
Clin Infect Dis
; 76(5): 881-889, 2023 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36250382
17.
Successful Treatment of Prolonged, Severe Coronavirus Disease 2019 Lower Respiratory Tract Disease in a B cell Acute Lymphoblastic Leukemia Patient With an Extended Course of Remdesivir and Nirmatrelvir/Ritonavir.
Clin Infect Dis
; 76(5): 926-929, 2023 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36326680
18.
Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.
Lancet
; 399(10330): 1141-1153, 2022 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35305740
19.
Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial.
Ann Intern Med
; 175(9): 1258-1265, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35785530
20.
Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk.
J Infect Dis
; 226(2): 246-257, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35758878